PLASMA LEVELS AND URINARY EXCRETION OF BATROXOBIN AND ITS DEFIBRINOGENATING EFFECTS IN VARIOUS ANIMAL SPECIES
スポンサーリンク
概要
- 論文の詳細を見る
The plasma levels and urinary excretion of batroxobin administered to 6 species of animals were examined by an enzyme immunoassay method. Defibrinogenating effect of batroxobin was also studied in those species. The plasma levels of immunoreactive batroxobin disappeared exponentially in all the animals and differences in half-life were observed to occur according to species. The elimination half-life of immunoreactive batroxobin in the plasma was the largest in dogs, followed by rats, monkeys, guinea pigs, mice and rabbits. The extent of the defibrinogenating effect was also noted to vary according to the species, being greatest in dogs and then monkeys, mice, rats, guinea pigs and rabbits. Following the continuous infusion of batroxobin into dogs, its level in the plasma remained high over a considerable period of time and the defibrinogenating effect lasted in corresponding to its plasma level. The urinary excretion of immunoreactive batroxobin was quite small in these species, being 0.2-1.9% of the original dose.
- 日本トキシコロジー学会の論文
- 1986-05-25
著者
-
Baba Shigeo
Department of Cardiovascular Medicine, Graduate School of Medicine Tohoku University
-
Baba S
Tokyo Coll. Pharmacy Tokyo Jpn
-
Baba Shigeo
Department Of Cardiovascular Medicine Graduate School Of Medicine Tohoku University
-
Imamura Yasushi
Koganei Research Laboratories Tobishi Pharmaceutical Co. Ltd.
-
SUGAI Ken-ichi
Koganei Research Laboratories, Tobishi Pharmaceutical Co., Ltd.
-
MIHASHI Susumu
Koganei Research Laboratories, Tobishi Pharmaceutical Co., Ltd.
-
MORI Noboru
Koganei Research Laboratories, Tobishi Pharmaceutical Co., Ltd.
-
OHBA Mitsuoki
Koganei Research Laboratories, Tobishi Pharmaceutical Co. Ltd.
-
KUNIKANE Kazutoshi
Koganei Research Laboratories, Tobishi Pharmaceutical Co. Ltd.
-
Mihashi Susumu
Koganei Research Laboratories Tobishi Pharmaceutical Co. Ltd.
-
Mori N
Koganei Research Laboratories Tobishi Pharmaceutical Co. Ltd.
-
Ohba Mitsuoki
Koganei Research Laboratories Tobishi Pharmaceutical Co. Ltd.
-
Sugai Ken-ichi
Koganei Research Laboratories Tobishi Pharmaceutical Co. Ltd.
-
Kunikane Kazutoshi
Koganei Research Laboratories Tobishi Pharmaceutical Co. Ltd.
-
MORI Noboru
Koganei Research Laboratories, Tobishi Pharmaceutical Co. Ltd.
関連論文
- Monophasic Action Potential Duration at the Crista Terminalis in Patients With Sinus Node Disease
- The Rise Time of the Monophasic Action Potential : A New Index of Loca Use-Dependent Conductivity by Sodium Channel Blockers in Human Myocardium
- Expression of the von Willebrand Factor in Atrial Endocardium is Increased in Atrial Fibrillation Depending on the Extent of Structural Remodeling
- Increased synthesis of von Willebrand factor in the endocardial endothelium as a prothrombotic alteration in atrial fibrillation involving structural remodeling
- METABOLIC FATE OF ^I-LABELED BATROXOBIN IN RATS AND DOGS
- PLASMA LEVELS AND URINARY EXCRETION OF BATROXOBIN AND ITS DEFIBRINOGENATING EFFECTS IN VARIOUS ANIMAL SPECIES
- Extracell ular matrix alterations associated with lipoprotein accumulation in diffuse intimal thickening of human coronary arteries
- Atheroma core formation in human coronary arteries may occur by inadequate cellular processing of plasma-derived lipoproteins
- Three-Dimensional Evaluation of Cardiac Resynchronization Using Gated Myocardial Perfusion Single Photon Emission Computed Tomography(Heart Failure, Clinical 3 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- DIFFERENTIATION BETWEEN ENDOGENOUS AND EXOGENOUS TESTOSTERONE IN HUMAN PLASMA AFTER ORAL ADMINISTRATION OF DEUTERIUM-LABELED TESTOSTERONE BY MASS FRAGMENTOGRAPHY